Fox Chase Cancer Center: Rectal Neoplasms trials

The registry lists 10 Rectal Neoplasms studies with Fox Chase Cancer Center as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 4Phase 2 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Adaptive Radiation Boost for Rectal CancerRecruitingNCT07221058Phase 1
• Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerTerminatedNCT01285102Phase 1Results posted
• Feasibility Bowel Dysfunction Program After Low Anterior ResectionCompletedNCT04733794Not applicable
• Organ Preservation in Early Rectal Cancer PatientsActive, not recruitingNCT03548961Phase 2
• Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationCompletedNCT02132858
• Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverTerminatedNCT02110953Phase 1
• Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing ChemotherapyTerminatedNCT01934179
• Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
• Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00084591Phase 1
• Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal CancerCompletedNCT00021398Phase 2